Abortion medication access, like mifepristone, is unchanged under Trump, but FDA reviews, lawsuits and state enforcement are creating risks for drugmakers.
A group of Texans is trying to bring attention to a new anti-abortion law that takes effect this week, saying it puts the health of pregnant patients at risk.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback